These data showed that treatment with anti-PD-L1 antibodies significantly reduced the infiltration of M2 into tumors, while the combined therapy of PD-L1 antibodies and IPI-549 significantly inhibited tumor growth [88]. Here, CD274 is linked to neoplasm.